» Articles » PMID: 23961257

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma

Overview
Publisher Thieme
Specialty Nuclear Medicine
Date 2013 Aug 21
PMID 23961257
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET-CT) for the evaluation of cutaneous melanoma has been demonstrated previously. However, there are few reports regarding the use PET-CT for the staging of conjunctival melanoma (CM). We report here a case, a 34-year-old male with a six-month history of a pigmented nodule at the palpebral conjunctiva of the left eye, and a firm left preauricular lymph node detected on physical examination. Biopsy of the ocular lesion confirmed CM, and fine needle aspiration cytology of the preauricular node was positive for malignancy. CT showed three pulmonary nodules. An (18)F-FDG PET-CT was performed to restage the patient. The study showed hypermetabolic lesions in the left eye, and in the left preauricular node. The scan was negative for metastasis. These findings were important in guiding management of the disease in this patient. Future prospective studies should further evaluate the role of (18)F-FDG PET-CT for the staging of CM.

Citing Articles

Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives.

Nahon-Esteve S, Bertolotto C, Picard-Gauci A, Gastaud L, Baillif S, Hofman P Cancers (Basel). 2021; 13(22).

PMID: 34830847 PMC: 8616295. DOI: 10.3390/cancers13225691.


Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.

Jain P, Finger P, Fili M, Damato B, Coupland S, Heimann H Br J Ophthalmol. 2020; 105(10):1358-1364.

PMID: 32892167 PMC: 8479743. DOI: 10.1136/bjophthalmol-2020-316293.


PET/CT and PET/MRI in ophthalmic oncology (Review).

Kalemaki M, Karantanas A, Exarchos D, Detorakis E, Zoras O, Marias K Int J Oncol. 2020; 56(2):417-429.

PMID: 31939615 PMC: 6959466. DOI: 10.3892/ijo.2020.4955.


Advances in the management of conjunctival melanoma.

Vora G, Demirci H, Marr B, Mruthyunjaya P Surv Ophthalmol. 2016; 62(1):26-42.

PMID: 27321895 PMC: 5353981. DOI: 10.1016/j.survophthal.2016.06.001.


Management of conjunctival malignant melanoma: a review and update.

Wong J, Nanji A, Galor A, Karp C Expert Rev Ophthalmol. 2015; 9(3):185-204.

PMID: 25580155 PMC: 4285629. DOI: 10.1586/17469899.2014.921119.

References
1.
Saornil M, Becerra E, Mendez M, Blanco G . [Conjunctival tumors]. Arch Soc Esp Oftalmol. 2009; 84(1):7-22. DOI: 10.4321/s0365-66912009000100003. View

2.
Shields C, Shields J . Ocular melanoma: relatively rare but requiring respect. Clin Dermatol. 2008; 27(1):122-33. DOI: 10.1016/j.clindermatol.2008.09.010. View

3.
Fletcher J, Djulbegovic B, Soares H, Siegel B, Lowe V, Lyman G . Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008; 49(3):480-508. DOI: 10.2967/jnumed.107.047787. View

4.
Shulman J, Latkany P, Chin K, Finger P . Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis. Ocul Immunol Inflamm. 2009; 17(2):95-100. DOI: 10.1080/09273940802596567. View

5.
Kurli M, Chin K, Finger P . Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma. Br J Ophthalmol. 2008; 92(4):479-82. DOI: 10.1136/bjo.2007.124339. View